{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T04:34:47Z","timestamp":1783658087035,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T00:00:00Z","timestamp":1484870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T00:00:00Z","timestamp":1484870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Pepstatin is a potent peptidyl inhibitor of various malarial aspartic proteases, and also has parasiticidal activity. Activity of pepstatin against cultured <jats:italic>Plasmodium falciparum<\/jats:italic> is highly variable depending on the commercial source. Here we identify a minor contaminant (pepstatin butyl ester) as the active anti-parasitic principle. We synthesize a series of derivatives and characterize an analogue (pepstatin hexyl ester) with low nanomolar activity. By selecting resistant parasite mutants, we find that a parasite esterase, PfPARE (<jats:italic>P. falciparum<\/jats:italic> Prodrug Activation and Resistance Esterase) is required for activation of esterified pepstatin. Parasites with esterase mutations are resistant to pepstatin esters and to an open source antimalarial compound, MMV011438. Recombinant PfPARE hydrolyses pepstatin esters and de-esterifies MMV011438. We conclude that (1) pepstatin is a potent but poorly bioavailable antimalarial; (2) PfPARE is a functional esterase that is capable of activating prodrugs; (3) Mutations in PfPARE constitute a mechanism of antimalarial resistance.<\/jats:p>","DOI":"10.1038\/ncomms14240","type":"journal-article","created":{"date-parts":[[2017,1,20]],"date-time":"2017-01-20T11:13:58Z","timestamp":1484910838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Esterase mutation is a mechanism of resistance to antimalarial compounds"],"prefix":"10.1038","volume":"8","author":[{"given":"Eva S.","family":"Istvan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy P.","family":"Mallari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria C.","family":"Corey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neekesh V.","family":"Dharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garland R.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Winzeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,20]]},"reference":[{"key":"BFncomms14240_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley, E. A. et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 371, 411\u2013423 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms14240_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.4269\/ajtmh.15-0007","volume":"93","author":"L Cui","year":"2015","unstructured":"Cui, L., Mharakurwa, S., Ndiaye, D., Rathod, P. K. & Rosenthal, P. J. Antimalarial drug resistance: literature review and activities and findings of the ICEMR network. Am. J. Trop. Med. Hyg. 93, 57\u201368 (2015).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"BFncomms14240_CR3","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nrd2972","volume":"8","author":"TN Wells","year":"2009","unstructured":"Wells, T. N., Alonso, P. L. & Gutteridge, W. E. New medicines to improve control and contribute to the eradication of malaria. Nat. Rev. Drug Discov. 8, 879\u2013891 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFncomms14240_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.7164\/antibiotics.23.259","volume":"23","author":"H Umezawa","year":"1970","unstructured":"Umezawa, H., Aoyagi, T., Morishima, H., Matsuzaki, M. & Hamada, M. Pepstatin, a new pepsin inhibitor produced by Actinomycetes. J. Antibiot. (Tokyo) 23, 259\u2013262 (1970).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"BFncomms14240_CR5","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1128\/AAC.42.9.2254","volume":"42","author":"A Semenov","year":"1998","unstructured":"Semenov, A., Olson, J. E. & Rosenthal, P. J. Antimalarial synergy of cysteine and aspartic protease inhibitors. Antimicrob. Agents Chemother. 42, 2254\u20132258 (1998).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms14240_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0166-6851(86)90095-2","volume":"18","author":"DL Vander Jagt","year":"1986","unstructured":"Vander Jagt, D. L., Hunsaker, L. A. & Campos, N. M. Characterization of a hemoglobin-degrading, low molecular weight protease from Plasmodium falciparum. Mol. Biochem. Parasitol. 18, 389\u2013400 (1986).","journal-title":"Mol. Biochem. Parasitol."},{"key":"BFncomms14240_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2307\/3280435","volume":"67","author":"HS Banyal","year":"1981","unstructured":"Banyal, H. S., Misra, G. C., Gupta, C. M. & Dutta, G. P. Involvement of malarial proteases in the interaction between the parasite and host erythrocyte in Plasmodium knowlesi infections. J. Parasitol. 67, 623\u2013626 (1981).","journal-title":"J. Parasitol."},{"key":"BFncomms14240_CR8","doi-asserted-by":"publisher","first-page":"8840","DOI":"10.1073\/pnas.0601876103","volume":"103","author":"J Liu","year":"2006","unstructured":"Liu, J., Istvan, E. S., Gluzman, I. Y., Gross, J. & Goldberg, D. E. Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems. Proc. Natl Acad. Sci. USA 103, 8840\u20138845 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms14240_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1365-2958.2007.05768.x","volume":"65","author":"JA Bonilla","year":"2007","unstructured":"Bonilla, J. A., Bonilla, T. D., Yowell, C. A., Fujioka, H. & Dame, J. B. Critical roles for the digestive vacuole plasmepsins of Plasmodium falciparum in vacuolar function. Mol. Microbiol. 65, 64\u201375 (2007).","journal-title":"Mol. Microbiol."},{"key":"BFncomms14240_CR10","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1128\/AAC.38.12.2871","volume":"38","author":"PK Rathod","year":"1994","unstructured":"Rathod, P. K., Khosla, M., Gassis, S., Young, R. D. & Lutz, C. Selection and characterization of 5-fluoroorotate-resistant Plasmodium falciparum. Antimicrob. Agents Chemother. 38, 2871\u20132876 (1994).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms14240_CR11","doi-asserted-by":"publisher","first-page":"13554","DOI":"10.1074\/jbc.M413556200","volume":"280","author":"RT Eastman","year":"2005","unstructured":"Eastman, R. T. et al. Resistance to a protein farnesyltransferase inhibitor in Plasmodium falciparum. J. Biol. Chem. 280, 13554\u201313559 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFncomms14240_CR12","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1046\/j.1365-2958.2003.03491.x","volume":"48","author":"K Fischer","year":"2003","unstructured":"Fischer, K. et al. Ten families of variant genes encoded in subtelomeric regions of multiple chromosomes of Plasmodium chabaudi, a malaria species that undergoes antigenic variation in the laboratory mouse. Mol. Microbiol. 48, 1209\u20131223 (2003).","journal-title":"Mol. Microbiol."},{"key":"BFncomms14240_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0076-6879(97)84006-2","volume":"284","author":"JD Schrag","year":"1997","unstructured":"Schrag, J. D. & Cygler, M. Lipases and alpha\/beta hydrolase fold. Methods Enzymol. 284, 85\u2013107 (1997).","journal-title":"Methods Enzymol."},{"key":"BFncomms14240_CR14","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jsb.2011.06.008","volume":"175","author":"S Thoms","year":"2011","unstructured":"Thoms, S., Hofhuis, J., Thoing, C., Gartner, J. & Niemann, H. H. The unusual extended C-terminal helix of the peroxisomal alpha\/beta-hydrolase Lpx1 is involved in dimer contacts but dispensable for dimerization. J. Struct. Biol. 175, 362\u2013371 (2011).","journal-title":"J. Struct. Biol."},{"key":"BFncomms14240_CR15","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.jmb.2015.01.023","volume":"427","author":"PA Schmidpeter","year":"2015","unstructured":"Schmidpeter, P. A. & Schmid, F. X. Prolyl isomerization and its catalysis in protein folding and protein function. J. Mol. Biol. 427, 1609\u20131631 (2015).","journal-title":"J. Mol. Biol."},{"key":"BFncomms14240_CR16","doi-asserted-by":"publisher","first-page":"11901","DOI":"10.1038\/ncomms11901","volume":"7","author":"VC Corey","year":"2016","unstructured":"Corey, V. C. et al. A broad analysis of resistance development in the malaria parasite. Nat. Commun. 7, 11901 (2016).","journal-title":"Nat. Commun."},{"key":"BFncomms14240_CR17","doi-asserted-by":"publisher","first-page":"e1005763","DOI":"10.1371\/journal.ppat.1005763","volume":"12","author":"WC Van Voorhis","year":"2016","unstructured":"Van Voorhis, W. C. et al. Open source drug discovery with the malaria box compound collection for neglected diseases and beyond. PLoS Pathog. 12, e1005763 (2016).","journal-title":"PLoS Pathog."},{"key":"BFncomms14240_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/289081a0","volume":"289","author":"G Darby","year":"1981","unstructured":"Darby, G., Field, H. J. & Salisbury, S. A. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance. Nature 289, 81\u201383 (1981).","journal-title":"Nature"},{"key":"BFncomms14240_CR19","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/358591a0","volume":"358","author":"Y Zhang","year":"1992","unstructured":"Zhang, Y., Heym, B., Allen, B., Young, D. & Cole, S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358, 591\u2013593 (1992).","journal-title":"Nature"},{"key":"BFncomms14240_CR20","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1365-2958.1998.00806.x","volume":"28","author":"A Goodwin","year":"1998","unstructured":"Goodwin, A. et al. Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene (rdxA) that encodes an oxygen-insensitive NADPH nitroreductase. Mol. Microbiol. 28, 383\u2013393 (1998).","journal-title":"Mol. Microbiol."},{"key":"BFncomms14240_CR21","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1128\/AAC.00909-08","volume":"53","author":"D Pal","year":"2009","unstructured":"Pal, D. et al. Giardia, Entamoeba, and Trichomonas enzymes activate metronidazole (nitroreductases) and inactivate metronidazole (nitroimidazole reductases). Antimicrob. Agents Chemother. 53, 458\u2013464 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFncomms14240_CR22","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0076-6879(72)25059-5","volume":"25","author":"PE Wilcox","year":"1972","unstructured":"Wilcox, P. E. [55] esterification. Methods Enzymol. 25, 596\u2013615 (1972).","journal-title":"Methods Enzymol."},{"key":"BFncomms14240_CR23","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager, W. & Jensen, J. B. Human malaria parasites in continuous culture. Science 193, 673\u2013675 (1976).","journal-title":"Science"},{"key":"BFncomms14240_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1083\/jcb200307147","volume":"164","author":"M Klemba","year":"2004","unstructured":"Klemba, M., Beatty, W., Gluzman, I. & Goldberg, D. E. Trafficking of plasmepsin II to the food vacuole of the malaria parasite Plasmodium falciparum. J. Cell Biol. 164, 47\u201356 (2004).","journal-title":"J. Cell Biol."},{"key":"BFncomms14240_CR25","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.1038\/ncomms5467","volume":"5","author":"AM Guggisberg","year":"2014","unstructured":"Guggisberg, A. M. et al. A sugar phosphatase regulates the methylerythritol phosphate (MEP) pathway in malaria parasites. Nat. Commun. 5, 4467 (2014).","journal-title":"Nat. Commun."},{"key":"BFncomms14240_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2105-15-63","volume":"15","author":"MJ Manary","year":"2014","unstructured":"Manary, M. J. et al. Identification of pathogen genomic variants through an integrated pipeline. BMC Bioinformatics 15, 63 (2014).","journal-title":"BMC Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms14240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms14240","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms14240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:04:08Z","timestamp":1671753848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms14240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,20]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,4,28]]}},"alternative-id":["BFncomms14240"],"URL":"https:\/\/doi.org\/10.1038\/ncomms14240","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,20]]},"assertion":[{"value":"18 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14240"}}